Abstract:OBJECTIVEHepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Hepatic arterial chemoembolization transcatheter (TACE) is one of the main treatment methods for liver cancer. However, the long-term therapeutic effect of HCC after TACE is still unsatisfactory, postoperative recurrence and metastasis rate is still very high. Furthermore, TACE operation due to liver cancer tissue ischemia and hypoxia will lead to up-regulation of vascular endothelial growth factor (VEGF) expression. In the current study, we investigated the effects of suppressed VEGF on HCC and its molecular mechanism provided a basis for targeting angiogenesis.MATERIALS AND METHODSWe established rabbits primary HCC model by in situ embedding the VX2 subcutaneous transplantation tumor. Conventional Seldinger femoral artery and hepatic artery catheterization method were used to select the catheter over the tumor-bearing hepatic artery. The different groups were divided into TACE operation, and the experimental group was performed with the VEGF-siRNA molecular preparation in the catheter. 64-slice spiral CT were used to perfusion imaging of liver cancer model before and after TACE operation. We further assessed the efficiency of VEGF silencing and its influence on VX2 cells. The expression of VEGF mRNA and protein were detected by RT-PCR and Western blotting, respectively. Intratumoral microvessel density (MVD), VEGF and CD34 were evaluated by immunohistochemistry. We detected the cell apoptotic by immunofluorescence and flow cytometry.RESULTSOur findings indicated that VEGF-siRNA-2# could effectively suppress the expression of VEGF expression, inhibited the proliferation capability and promoted apoptosis of VX2 cells in vitro. Silencing of VEGF expression also suppress HCC tumor growth and reduce HCC angiogenesis in rabbits primary HCC model in vivo. Furthermore, We found that phosphoinositide 3-kinase (PI3K) and protein kinase B (AKT) activation were considerably reduced while inhibition VEGF expression in VX2 cells.CONCLUSIONSOur data demonstrated that VEGF silencing could suppress cells proliferation, promote cells apoptosis and reduce HCC angiogenesis through inactivation of VEGF/PI3K/AKT signaling pathway.

Construction of Lentiviral Vector Based Small Interference RNA Targeting Human IKKá and IKKa Gene and Its Suppressive Effect on Hepatocellular Carcinoma

Construction and identification of vector against Kir6.2 gene expression in hepatoma cells by short interfering RNAs

Construction of Microrna Let-7C Lentiviral Vector and Its Overexpression

[Construction of Shrna Expression Vector Silencing Kir6.2 Gene and to Study Its Influence on the Proliferation and Invasion of HepG2 Cells].

BC047440 silencing in HepG2 cells mediated by lentiviral vector

Role of RhoC-siRNA Expression Vector on Growth Velocity and Invasiveness of Hepatoma Carcinoma Cells

BC047440 Antisense Eukaryotic Expression Vectors Inhibited HepG2 Cell Proliferation and Suppressed Xenograft Tumorigenicity.

Construction of hsa-miR-152lentiviral vector and screening of cell strain for stable expression

Construction of RhoC-siRNA expression vector and its role in invasion and metastasis ability of hepatoma carcinoma cell

Construction of LASS2 gene recombinant adenovirus and its effect on the inhibition of metastasis of hepatocellular carcinoma cell line HCCLM3

Cell-Specific Expression of Artificial Micrornas Targeting Essential Genes Exhibit Potent Antitumor Effect on Hepatocellular Carcinoma Cells

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

[Construction of Mirna Expression Vector Dual-Targeting on HIF-1α/survivin Genes and Its Effects on Proliferation of Pancreatic Cancer Panc-1 Cell Line].

DNA Polymerases as targets for gene therapy of hepatocellular carcinoma

Inhibition of Human Hepatocellular Carcinoma Tumor Angiogenesis by Sirna Silencing of VEGF Via Hepatic Artery Perfusion.

Construction of heparanase gene-targeted small interfering RNA and its gene silencing effect]

Construction and Identification of a Recombinant Lentiviral Vector of RNA Interference of Lung Cancer Related Gene SLC35F2

Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma in Vitro and in Vivo

Construction and Identification of Lentiviral Vector Containing Human ILK-shRNA and Mda7 Gene

Construction of shRNA Lentiviral Vector Targeting Mice IL-35 Gene and Identification of RNAi Efficiency

Hepatitis B Virus Inhibition in Mice by Lentiviral Vector Mediated Short Hairpin RNA.